New approval includes older adolescents and adults with rare disease
Updated Date: Fri, 25 Sep 2020 00:00:00 EDT
Updated Date: Fri, 25 Sep 2020 00:00:00 EDT
Updated Date: Fri, 25 Sep 2020 00:00:00 EDT
Updated Date: Fri, 25 Sep 2020 00:00:00 EDT
Updated Date: Fri, 25 Sep 2020 00:00:00 EDT
Trump takes Regeneron’s experimental antibodies hours after COVID-19 diagnosis kblankenship Fri, 10/02/2020 – 17:32
A class of compounds used for malaria treatment also kill the intestinal parasite Cryptosporidium, a leading cause of […]
For the first time, researchers at the Centre for Proton Therapy at the Paul Scherrer Institute PSI in […]
